Skip to main content
logo
IDNA Genomics Public Ltd (CYS:IDNA)
Cyprus flag Cyprus · Delayed Price · Currency is EUR
14.80
0.00 (0.00%)
At close: Aug 31, 2026

IDNA Genomics Public Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Income
-2.24-2.52-1.34
Depreciation & Amortization
0.320.290.24
Loss (Gain) From Sale of Assets
---0.09
Asset Writedown & Restructuring Costs
1.11.34-
Other Operating Activities
-1.03-0.30.14
Change in Accounts Receivable
0.03-0.12-0.02
Change in Inventory
-0.04-0.05-0.05
Change in Accounts Payable
1.62-1.151.12
Operating Cash Flow
-0.25-2.52-0.01
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Capital Expenditures
-0-0.01-0
Divestitures
-2-
Sale (Purchase) of Intangibles
--0.17-0.7
Investment in Securities
---0.02
Investing Cash Flow
-01.82-0.72

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Long-Term Debt Issued
0.5-1.56
Long-Term Debt Repaid
-0.4-0.12-0.75
Net Debt Issued (Repaid)
0.1-0.120.81
Other Financing Activities
-0.2-0.15-0.13
Financing Cash Flow
-0.09-0.260.68

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Cash Flow
-0.34-0.96-0.05

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Free Cash Flow
-0.25-2.53-0.01
Free Cash Flow Growth
---
Free Cash Flow Margin
-50.83%-528.51%-2.62%
Free Cash Flow Per Share
-0.09-0.92-0.01
Levered Free Cash Flow
0.44-2.22-
Unlevered Free Cash Flow
0.56-2.13-

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Cash Interest Paid
0.20.150.13
Cash Income Tax Paid
0.030.01-
Change in Working Capital
1.61-1.321.05